|
Micardis Given Wider Approval
For cardiac patients who can't take an ACE inhibitor
Mon Oct 19, 2009, 14:29
|
Story Tools
|
|
•
|
Printable
version
|
|
•
|
Oct 19, 2009 News
|
|
Related News Categories
| | • | Heart / Stroke-Related: Misc | | • | Heart / Stroke-Related: High Blood Pressure | | • | Heart / Stroke-Related: Heart Attack | | • | Heart / Stroke-Related Problems: Stroke | | • | Food & Drug Administration | | • | Drug Approvals |
Related News
| • | Salt Really Does Boost Health Risks - Nov 25, 2009 | • | Ginkgo Won't Prevent Heart Attack, Stroke in Elderly - Nov 24, 2009 | • | Angioplasty Outcomes May Vary Little Between Hospitals - Nov 24, 2009 | • | Cholesterol Plays Role in Heart Failure Risk - Nov 24, 2009 | • | Smokers Double Their Risk for Heart Disease - Nov 24, 2009 | • | Stifled Anger at Work Doubles Men's Risk for Heart Attack - Nov 24, 2009 | • | Vioxx Problems Known Years Before Recall - Nov 23, 2009 | • | Doctor-Pharmacist Teams Boost Blood Pressure Control - Nov 23, 2009 | • | Vigorous Exercise Cuts Stroke Risk for Men, Not Women - Nov 23, 2009 | • | Moderate Drinking Guards the Heart - Nov 19, 2009 | • | Kidney Transplant, Sleep Disorder May Add Up to Trouble - Nov 19, 2009 | • | Diet, Cognitive Ability May Play Role in Heart Disease - Nov 19, 2009 | • | For Chest Pain in the ER, CT Angiography May Be Best - Nov 19, 2009 | • | Diuretics Still Best Treatment for High Blood Pressure - Nov 18, 2009 | • | Newer Blood Thinners May Outperform Old Standbys - Nov 18, 2009 |
MONDAY, Oct. 19 (HealthDay News) -- Micardis (telmisartan) has received expanded approval from the U.S. Food and Drug Administration to reduce the risk of heart attack or stroke in people 55 or older who cannot take a class of cardiovascular drugs called ACE inhibitors, maker Boehringer Ingelheim said Monday.
Micardis belongs to its own class called angiotensin II receptor blockers. It's been available in the United States since 1998 to treat high blood pressure.
The FDA also granted new approval for a drug called Twynsta, which combines the active ingredient in Micardis with the calcium channel blocker amlodipine. The combination drug is meant to prevent high blood pressure when used alone, or in tandem with other anti-hypertension drugs, Boehringer said in a news release.
Some studies estimate that as many as 20 percent of people taking ACE inhibitors have side effects, which could prevent the drugs' use as prescribed, the company said. Micardis has possible side effects of its own, including upper respiratory infection, back pain, sinusitis and diarrhea. The drug shouldn't be used by pregnant women, Boehringer said.
More information
To learn more about this drug, visit the U.S. National Library of Medicine.
Copyright © 2009 ScoutNews, LLC. All rights reserved.
Today's Top News Stories | • | Cetuximab Helps Treat Colorectal Cancer - Nov 25, 2009, 12:00
Drug plus chemo boosts surgery success for patients with liver lesions, researchers find. | • | Salt Really Does Boost Health Risks - Nov 25, 2009, 09:00
Links to stroke, cardiovascular disease may make a case for population-wide reduction, review finds. | • | Natural Soy Component May Help Treat Colon Cancer - Nov 25, 2009, 12:00
Discovery in fruit fly study may lead to new drugs for people, researchers say. | • | Holiday Eating Without the Guilt -- or the Pounds - Nov 25, 2009, 12:00
Two experts offer waistline-friendly ways to enjoy festive feasting. | • | ER Visits for Elderly Rise During Thanksgiving - Nov 25, 2009, 09:00
Experts say family members can panic, underestimate effects of normal aging. |
|
|
|
